Ghent University Academic Bibliography

Advanced

Lanreotide autogel in the treatment of idiopathic refractory diarrhea : results of an exploratory, controlled, before and after, open-label, multicenter, prospective clinical trial

Raf Bisschops, Vincent De Ruyter, Gauthier Demolin, Didier Baert, Tom Moreels, Piet Pattyn UGent, Hans Verhelst, Luc Lepoutre, Joris Arts, Philip Caenepeel, et al. (2016) CLINICAL THERAPEUTICS. 38(8). p.1902-1911
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
chronic idiopathic refractory diarrhea, gastrointestinal motility, lanreotide Autogel, open-label clinical trial, somatostatin analogue, MALIGNANT CARCINOID-SYNDROME, LONG-ACTING FORMULATION, SOMATOSTATIN ANALOG, OCTREOTIDE, MANAGEMENT
journal title
CLINICAL THERAPEUTICS
Clin. Ther.
volume
38
issue
8
pages
1902 - 1911
Web of Science type
Article
Web of Science id
000382413100013
JCR category
PHARMACOLOGY & PHARMACY
JCR impact factor
2.947 (2016)
JCR rank
93/256 (2016)
JCR quartile
2 (2016)
ISSN
0149-2918
DOI
10.1016/j.clinthera.2016.06.012
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
8502796
handle
http://hdl.handle.net/1854/LU-8502796
date created
2017-01-18 14:18:01
date last changed
2017-02-20 10:30:27
@article{8502796,
  author       = {Bisschops, Raf and De Ruyter, Vincent and Demolin, Gauthier and Baert, Didier and Moreels, Tom and Pattyn, Piet and Verhelst, Hans and Lepoutre, Luc and Arts, Joris and Caenepeel, Philip and Ooghe, Patrick and Codden, Thierry and Maisonobe, Pascal and Petrens, Elke and Tack, Jan},
  issn         = {0149-2918},
  journal      = {CLINICAL THERAPEUTICS},
  keyword      = {chronic idiopathic refractory diarrhea,gastrointestinal motility,lanreotide Autogel,open-label clinical trial,somatostatin analogue,MALIGNANT CARCINOID-SYNDROME,LONG-ACTING FORMULATION,SOMATOSTATIN ANALOG,OCTREOTIDE,MANAGEMENT},
  language     = {eng},
  number       = {8},
  pages        = {1902--1911},
  title        = {Lanreotide autogel in the treatment of idiopathic refractory diarrhea : results of an exploratory, controlled, before and after, open-label, multicenter, prospective clinical trial},
  url          = {http://dx.doi.org/10.1016/j.clinthera.2016.06.012},
  volume       = {38},
  year         = {2016},
}

Chicago
Bisschops, Raf, Vincent De Ruyter, Gauthier Demolin, Didier Baert, Tom Moreels, Piet Pattyn, Hans Verhelst, et al. 2016. “Lanreotide Autogel in the Treatment of Idiopathic Refractory Diarrhea : Results of an Exploratory, Controlled, Before and After, Open-label, Multicenter, Prospective Clinical Trial.” Clinical Therapeutics 38 (8): 1902–1911.
APA
Bisschops, R., De Ruyter, V., Demolin, G., Baert, D., Moreels, T., Pattyn, P., Verhelst, H., et al. (2016). Lanreotide autogel in the treatment of idiopathic refractory diarrhea : results of an exploratory, controlled, before and after, open-label, multicenter, prospective clinical trial. CLINICAL THERAPEUTICS, 38(8), 1902–1911.
Vancouver
1.
Bisschops R, De Ruyter V, Demolin G, Baert D, Moreels T, Pattyn P, et al. Lanreotide autogel in the treatment of idiopathic refractory diarrhea : results of an exploratory, controlled, before and after, open-label, multicenter, prospective clinical trial. CLINICAL THERAPEUTICS. 2016;38(8):1902–11.
MLA
Bisschops, Raf, Vincent De Ruyter, Gauthier Demolin, et al. “Lanreotide Autogel in the Treatment of Idiopathic Refractory Diarrhea : Results of an Exploratory, Controlled, Before and After, Open-label, Multicenter, Prospective Clinical Trial.” CLINICAL THERAPEUTICS 38.8 (2016): 1902–1911. Print.